http://www.fpnotebook.com/
Selective Serotonin Reuptake InhibitorAka: SSRI
- Indications: First Line
- Major Depression
- Generalized Anxiety Disorder
- Premature Ejaculation
- Indications: Adjunctive
- Adverse Effects of all SSRI
- Appetite suppression
- Sleep disturbance
- Galactorrhea
- Sexual Dysfunction
- Hyponatremia
- Consider monitoring Serum Sodium
- Upper Gastrointestinal Bleeding in over age 65 years
- Average rate: 7.3 per 1000 person years (6.6 - 7.9)
- Bleeding risk increased with SSRI potency
- Other Risk Factors
- Very old patients (where young is age 65 years)
- Prior history of Gastrointestinal Bleeding
- Diabetes Mellitus
- Medications (Coumadin, ASA, NSAIDs, Corticosteroid)
- References
- Average rate: 7.3 per 1000 person years (6.6 - 7.9)
- Precautions
- Avoid concurrent use with MAO inhibitor
- Risk of Serotonin Syndrome
- Avoid concurrent use with MAO inhibitor
- Overdose Symptoms and Signs
- Classes: Selective Serotonin Reuptake Inhibitors (SSRI)
- Monocyclic
- Bicyclic
- Fluoxetine HCl (Prozac)
- Tricyclic
- Sertraline HCl (Zoloft)
- Tetracyclic
- Paroxetine HCl (Paxil)
- Classes: Other new Antidepressants (non-SSRI)
- See Antidepressant
- Serotonin Norepinephrine Reuptake Inhibitors (SNRI)
- Venlafaxine (Effexor)
- Same class as Tricyclic Antidepressants
- Norepinephrine Dopamine Reuptake Inhibitor (NDRI)
- Serotonin Antagonist and Reuptake Inhibitor (SARI)
- Nefazodone (Serzone)
- Same class as Trazodone (Desyrel)
- Norepinephrine Antagonist Serotonin Antagonist (NASA)
- References
